On Marketing Approval Regulation of Biosimilars: A Model or a Lesson by the U.S. Biologics Price Competition and Innovation Act of 2009?
碩士 === 國立交通大學 === 管理學院科技法律學程 === 103 === The President Obama of United States signed the Biologics Price Competition and Innovation Act of 2009 (BPCI Act) into law on October 23rd, 2010, and initiated the official regulation of biosimilar by the largest single pharmaceutical market in the world. Fro...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2014
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/gfqcb5 |